A Novel Approach For 21-Genes Testing Associated With Prognosis In Chinese Patients With Er-Positive/Her2-Negative Breast Cancer: A Real-World Study.

Yinduo Zeng,Qian Li,Jiannan Wu,Heran Deng,Ying Wang,Wenjing Wu,Jianli Zhao,Xiao-Xiao Dinglin,Tao Qin,Qiang Liu,Fengxi Su,Weijuan Jia,Herui Yao

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览73

暂无评分

摘要

e12528Background: We previously reported a Chinese version of 21-genes Recurrence Score (RS) provides reduction chemotherapy prescription in patients with ER-Positive/HER2-Negative node negative br...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要